Marginal Zone Lymphoma
Marginal Zone Lymphoma (MZL) is a group of slow-growing NHL B-cell lymphomas that accounts for 8% of all new NHL cases, according to the Lymphoma Research Foundation. It is typically more common among women and older adults.
Massive Bio’s number one priority is to create positive outcomes for cancer patients. With the Clinical Trial Matching Service and Virtual Tumor Board, you are one step closer to reaching that positive outcome.
Cancer clinical trials are important for cancer treatment; they find and prove new ways to fight cancer. By participating in a clinical trial, you can find the best treatment for your Marginal Zone Lymphoma and help others who are struggling with MZL as well. Getting access to the right clinical trials and the right treatments should not have to be overwhelming. That is why Massive Bio uses the clinical trial matching service to match MZL patients to the right clinical trials based on the stage of the disease, biomarker status, geographical, location, and past medical history.
Effects of Marginal Zone Lymphoma
Why Join A Marginal Zone Lymphoma Clinical Trial?
Marginal zone lymphoma clinical trials give patients early access to new treatments that are in the process of being approved by the FDA (Food and Drug Administration). Clinical trials find new ways to treat, prevent, and diagnose cancer.
Our unique SYNERGY-AI Clinical Trial Matching System finds patients clinical trials right for their unique cancer case. The system finds trials according to location, disease stage and biomarker status.
Find Marginal Zone Lymphoma Clinical Trials
Massive Bio makes finding the right trial for your lymphoma case easy, because our team does all the work for you. Our matching tool is entirely virtual, meaning you can stay safe during the COVID-19 pandemic from the comfort of your home, up until the time of your first clinical trial site visit. Once patients receive their match results, a dedicated patient advocate guides them every step along the way, with the goal of following the path of the patient to provide a positive outcome. Contact us today to get your clinical trial match results.
We are unwavering in our commitment to create a world without cancer. We believe all people should have equal access to leading edge therapies and new-emerging clinical trials, regardless of where they live or their ability to pay.
Massive Bio will become the hub to connect patients to the best treatments available, including clinical trials. We will be the preferred partner for Patients, Healthcare Providers, Pharmaceutical Companies, and Clinical Research Organizations as we will create a space where we will connect the right patient, with the right treatment at the right time and place.
Find Clinical Trials
Do You Have Any Questions?
- Be one step closer to finding Marginal Zone Lymphoma treatments.
- Get a second opinion from US oncologists, without leaving your home.
- If you have relapsed, or current therapy has failed, there are more options for you.
- Access to clinical trials & immunotherapy treatment options.
Frequently Asked Questions Related to Marginal Zone Lymphoma
- The clinical trial matching system is available online and on our mobile app, SYNERGY-AI Cancer Trial Finder.
- We request medical records through fax.
- We send clinical trial match reports via email within 7-10 business days of receiving medical records.
- We will call you to discuss your clinical trial match report.
- There is no need to travel to a clinical trial site until enrollment is completed and the first appointment is scheduled.
Clinical trials give you early access to novel treatments that are being studied for approval by the FDA.
Join this Non-Hodgkin Lymphoma Facebook Group for Community Support
Patient's recently diagnosed or relapsed with Non-Hodgkin Lymphoma may wonder what the right next step to take is. Join a community of others who are going through Non-Hodgkin Lymphoma to discuss questions, concerns, and share stories.